The benefits of duloxetine, a drug used in Europe to treat stress incontinence in women, do not outweigh the harms.
Duloxetine, a drug approved in Canada, the US and Europe to treat major depression, is approved in Europe to treat stress urinary incontinence -- involuntary leakage of urine during exertion, sneezing or coughing -- that affects an estimated 1 in 10 women.
Urinary Incontinence Symptom Evaluation
Urinary incontinence is loss of bladder control causing urine leakage. Severe urine leakage can happen when one coughs, sneezes, or during a sudden urge, where one is unable to visit the restroom in time.
Advertisement
‘Though duloxetine reduces the frequency of incontinence, it has side effects such as violence and suicide attempts.’
Tweet it Now
The US Food and Drug Administration has noted a higher-than-expected rate of suicide attempts in open-label extensions of controlled trials of duloxetine for stress urinary incontinence.
Researchers from the Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark, looked at clinical study reports from the European Medicines Agency to assess the benefits and harms of using this drug for stress urinary incontinence.
![Incontinence-Involuntary Loss of Urine-An impact on the daily life solution]( "Incontinence-Involuntary Loss of Urine-An impact on the daily life solution")
Unintentional loss of urine has multiple implications to the sufferer. Urinary Incontinence has been noted to be a major barrier to social interests, entertainment, or physical recreation.
Although they found that duloxetine did lessen the frequency of incontinence, they also observed adverse effects associated with the drug. Harms potentially related to suicidality and violence were 4-5 times more common with duloxetine than with a placebo. "Given the uncertainty as to whether duloxetine leads to clinically significant improvement in quality of life ... we question the rationale for using duloxetine for stress urinary incontinence," writes Emma Maund, lead author and researcher at the Nordic Cochrane Centre, with coauthors.
Source: Eurekalert
Incontinence-Involuntary Loss of Urine-An impact on the daily life solution
Unintentional loss of urine has multiple implications to the sufferer. Urinary Incontinence has been noted to be a major barrier to social interests, entertainment, or physical recreation.
Advertisement
Although they found that duloxetine did lessen the frequency of incontinence, they also observed adverse effects associated with the drug. Harms potentially related to suicidality and violence were 4-5 times more common with duloxetine than with a placebo. "Given the uncertainty as to whether duloxetine leads to clinically significant improvement in quality of life ... we question the rationale for using duloxetine for stress urinary incontinence," writes Emma Maund, lead author and researcher at the Nordic Cochrane Centre, with coauthors.
Source: Eurekalert
Stress Incontinence
Stress incontinence is the most common type of urinary incontinence. Women are more prone to it than men.
Advertisement
 Urodynamic TestingWhat is urodynamic testing? When is it required? Find out what it is used for and if it is useful in the diagnosis of conditions responsible for urinary incontinence and urinary tract infections. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.